If you or a loved one were prescribed and took Invokana and then suffered kidney or heart-related side effects, you may be entitled to compensation.
May 23, 2017 - The U.S. FDA has determined that taking Invokana or Invokamet (canagliflozin metformin) can double the risk of foot and leg amputation in diabetes patients. Issuing a "boxed warning," the FDA will require manufacturers of Invokana to prominently display this warning on the drug's packaging. A boxed warning is the strongest warning the FDA requires, indicating severe or life-threatening effects. Read more about the diabetes drug being linked to amputation risk.
Invokana, marketed by Janssen Pharmaceutica, is a drug commonly prescribed to aid in treating high blood sugar (A1C) in people with type 2 diabetes. The lawsuits claim that doctors would have prescribed other drugs or treatments had they been made aware of the severity of heart and kidney side effects, including, but not limited to:
- Heart attacks
- Kidney disease
If this describes you or a loved one, the Kishish Law Group can help. Contact us today for a free and confidential case evaluation by using our contact form or calling us at 1 (888) 609-4664.
The U.S. F.D.A. warns consumers about Invokana
The U.S. Food and Drug Administration (F.D.A.) approved Invokana in 2013 as the first in a class of drugs called SGLT2 inhibitors. SGLT2 is a transporter protein that aids the kidneys in retention of glucose. By inhibiting this protein, Invokana and other similar drugs cause more blood sugar to be lost during urination, helping patients control their blood sugar levels.
In 2015, the F.D.A. published a safety announcement warning consumers of Invokana about the risk for a condition called ketoacidosis. During ketoacidosis, a lack of glucose absorption causes the body to over-produce ketone bodies leading to dangerous conditions that can require hospitalization. Symptoms of ketoacidosis include:
- Difficulty breathing
- Abdominal pain
Nearly seven months later, in December 2015, the F.D.A. issued another warning about Invokana and other SGLT2 inhibitors. At the time of this warning, the F.D.A. had identified 73 patients who had taken SGLT2 inhibitors and then developed ketoacidosis. All of these patients required emergency treatment or hospitalization. Additionally the F.D.A. reported cases where patients taking SGLT2 inhibitors had developed serious urinary tract infections resulting in kidney infections and life-threatening blood infections. In some of these cases, patients required dialysis to treat kidney failure.
In May 2016, the F.D.A. added additional warnings about Invokana, this time reporting that clinical trials had found an increased risk for amputation of legs and feet. Although the F.D.A. acknowledged that the trial was not definitive, they still warned users of the drug to monitor themselves for "new pain or tenderness, sores or ulcers, or infections in their legs or feet." One month later, the F.D.A. revised the labels for Invokana and other similar drugs to include warnings about acute kidney injury.
Do I have an Invokana lawsuit?
The Kishish Law Group is committed to seeking justice for you and your loved ones. We believe that you deserve fair compensation for your suffering and we will work tirelessly to achieve that goal. If you or a loved one suffered due to taking Invokana, we want to know.
DISCLAIMER: No attorney client relationship will exist between you and our firm until we enter into a signed Retainer/Services Agreement. Completion of this document is for informational purposes only and does not constitute a Retainer/Services Agreement. The information you obtain at this site is not, nor is it intended to be, legal advice. Contacting us does not create an attorney-client relationship. In some jurisdictions this website may be considered lawyer advertising. You should consult an attorney for advice regarding your individual situation. Click here for more information.
Speak with an Invokana Lawyer
If you or a loved one were prescribed and took Invokana (canagliflozin) and suffered injuries or serious side effects, you may be entitled to compensation.
Contact a lawyer today for a free and confidential legal consultation.
- April 1, 2020
FDA Requests Companies to Stop Selling All Zantac Products, Citing Cancer Concerns
- August 13, 2018
FDA Updates List of Valsartan Blood Pressure Medication Affected by Recall
- February 18, 2018
Invokana Lawsuits Rise, First Trial of Alleged Amputation Set for September
- June 12, 2017
Invokana Side Effects and Diabetic Ketoacidosis
- June 8, 2017
SGLT2 Inhibitors, like Invokana, Found to Double Risk of Diabetic Ketoacidosis